-
Mashup Score: 1When Philanthropy and Competition Go Hand-in-Hand: Leaders Nationwide are Helping Blood Cancer Patients Survive and Thrive - 10 month(s) ago
The Leukemia & Lymphoma Society Announces Winners of Visionaries of the Year Campaign
Source: MultiVuCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Today’s Diabetes Hits Different This American Diabetes Month For Over 133M Americans Living with Prediabetes and Diabetes - 2 year(s) ago
The American Diabetes Association®(ADA), the world’s leading diabetes organization, today unveiled this November’s American Diabetes Month.
Source: MultiVuCategories: Endocrinology, Latest HeadlinesTweet-
Today’s Diabetes Hits Different This American Diabetes Month For Over 133M Americans Living with Prediabetes and Diabetes https://t.co/WEYGsRdDjq
-
-
Mashup Score: 3The Leukemia & Lymphoma Society Announces “Visionaries of the Year” Campaigns to Advance Mission - 2 year(s) ago
Evolution of Man & Woman of the Year and Students of the Year campaigns honor the vision that dedicated leaders bring to making the impossible possible
Source: MultiVuCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0How One Powerful Philanthropic Competition is Taking the Fight Against Cancer by Storm - 2 year(s) ago
The adage that there’s power in numbers rings true and loud for the thousands of candidates who participated in Leukemia & Lymphoma Society’s 2022 Man&Woman
Source: MultiVuCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
Galderma Launches EPSOLAY Cream, a Medical Advance to Treat Bumps
Source: MultiVuCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 5FDA approves Novartis Leqvio® (inclisiran), first-in-class siRNA to lower cholesterol and keep it low with two doses a year - 2 year(s) ago
Novartis today announced the US Food and Drug Administration (FDA) approval of Leqvio® (inclisiran)
Source: MultiVuCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0FDA approves Novartis Leqvio® (inclisiran), first-in-class siRNA to lower cholesterol and keep it low with two doses a year - 2 year(s) ago
Novartis today announced the US Food and Drug Administration (FDA) approval of Leqvio® (inclisiran)
Source: MultiVuCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2This November, It's Up to Everyone to Put On Their Capes and Take A Stand Against Diabetes - 3 year(s) ago
In recognition of November as American Diabetes Month®, the American Diabetes Association® (Association) reminds us that there’s a hero inside everyone
Source: MultiVuCategories: Latest Headlines, PediatricsTweet
-
Mashup Score: 1
The Leukemia & Lymphoma Society announces record-breaking winners of 2021 Man & Woman of the Year fundraising competition
Source: MultiVuCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Thousands of high school students in hundreds of communities across the country have proven that nothing, not even a global pandemic, can stand in the way
Source: MultiVuCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
We are so grateful for the commitment, passion, and perseverance of our incredible National Visionaries of the Year top fundraisers! ❤️ Read on to learn more about their connections to blood cancer and game-changing efforts 👉 https://t.co/T9knIS4VlN